EssilorLuxottica SA (Euronext Paris:EL), a French-Italian manufacturer of ophthalmic lenses, frames and sunglasses, announced on Tuesday that it has acquired Cellview Imaging Inc, a Canadian med-tech start-up specialising in retinal imaging diagnostics.

This acquisition strengthens EssilorLuxottica's presence in the ophthalmic technology sector, advancing its portfolio of diagnostic instruments.

Toronto-based Cellview's ultra-widefield retinal camera enables eyecare professionals to capture high-quality images covering a significantly larger retinal area than most existing technologies for improved diagnosis of retinal pathologies. Currently available in North America, Cellview's FDA and CE-approved products serve both retail eyecare practices and ophthalmology clinics.

EssilorLuxottica plans to expand Cellview's reach, beginning with European markets, targeting a broad customer base including retail eyecare practices and ophthalmology clinics.

This acquisition aligns with EssilorLuxottica's strategy to enhance vision care through innovative medical technologies.